MedTrace Logo

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

NCT06495931 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-04-24

No results posted yet for this study

Summary

This study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.

Conditions

Interventions

DRUG

HRS-1780 tablets

HRS-1780 tablets, three times

DRUG

HR20033 tablets

HR20033 tablets, nine times

DRUG

HRS-7535 tablets

HRS-7535 tablets ，three times or nine times

Sponsors & Collaborators

  • Shandong Suncadia Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-08-13
Completion
2024-08-13

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495931 on ClinicalTrials.gov